MS is a disease of the central nervous system, estimated to affect 2.3 million people worldwide.more
Spinal Muscular Atrophy (SMA)
Roche has been working in partnership with the SMA community to transform outcomes for a broad range of people living with the rare, neurological condition.more
Neuromyelitis optica spectrum disorder (NMOSD)
NMOSD is a rare and lifelong autoimmune disease of the central nervous systemmore
Elevating the patient voice in Huntington’s disease
How patient partnership is shaping the future of research and clinical development for Huntington’s disease.more
Alzheimer’s disease is a progressive, fatal brain disease and the most common cause of dementia.more
HD affects approximately 1 in 10,000 people.
Find out more about this disease and how it impacts daily life?
Huntington’s disease – Advancing research to improve lives
Huntington’s disease can affect entire families, and much is still unknown about this complex brain disease, but through research, we hope to change that.
Autism Spectrum Disorder: A journey with unique challenges
Kathy Hyde hopes that telling her son’s story will help increase understanding of the challenges faced by individuals with autism spectrum disorder.more